Bruder Healthcare introduces Eyeleve MGD
With 80% of dry eye patients suffering from evaporative dry eye, Eyeleve MGD will serve a crucial need of patients and practitioners alike.
With 80% of dry eye patients suffering from evaporative dry eye, Eyeleve MGD will serve a crucial need of patients and practitioners alike.
NFL season predictions just got sweeter with the help of the SNICKERS SatisFORTUNES Bite Guide.
She brings over 25 years of media experience across retail, CPG, and agency sectors.
“At Rite Aid, we know our trusted pharmacy teams will be relied upon this respiratory season to help prevent the spread of viruses, including COVID-19,” said Chief Pharmacy Officer Karen Staniforth.
Company adds a decadent, delicious, and uniquely combined new product to the brand's fan-favorite product portfolio.
Ultrahuman Ring AIR becomes the first Smart Ring available at Verizon.
Aetna's landmark policy change increases access to family-building possibilities, regardless of sexual orientation or partner status.
The unique beauty bar, which features a tennis ball-inspired green hue and a passionfruit & lemon balm fragrance selected by Williams herself
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
"Vaccines are a critical tool that can help prevent the spread of diseases, maintain public health, and are one of our best defenses against these diseases," said Colleen Lindholz, president, Kroger Health.
New space supports advanced therapy solutions capabilities and dedication to life-saving treatments.
The National Community Pharmacists Association announced the featured presenters for its 2024 Annual Convention, set for Oct. 26-29 in Columbus, Ohio.
Year to date, major U.S. retailers have announced 4.0% more openings and 48.2% more closures when compared to the same time last year.
Brand aims to continue empowering consumers to celebrate their beauty with confidence.
Consumers look for deals and shop around to deal with inflation's impact on food prices
The approval is based on the full body of previous clinical, non-clinical, and real-world evidence supporting the safety and effectiveness of the COVID-19 vaccines by Pfizer and BioNTech.